The global bio decontamination market is projected to grow from USD 370.17 million in 2026 to USD 599.89 million by 2032, at a CAGR of 8.39%. Growth is driven by stricter hygiene regulations, expansion in biologics and vaccines, and increased focus on infection prevention. Advances in AI and automation are enhancing contamination control through predictive maintenance, optimized cycles, and digital traceability. Regional opportunities vary, with strong demand in Asia-Pacific, North America, and Europe, reflecting differing regulatory and infrastructure priorities.
The global bio decontamination market forecast through 2032 provides context for health-sector trading on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 29, 2026 20:51 WIB: out of 150 priced US health-sector stocks, 126 rose and 24 fell. Among notable movers, HLN dropped 13.35% to USD 8.66 with a typical hold time of 15 days, contrasting with LLY which gained 7.70% to USD 1,387.98 and showed a strong buy order activity of 71% and a longer hold time of 94 days. CLPT also rose 6.06% to USD 11.20 but had balanced buy/sell orders and a shorter hold time of 11 days.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
